Trial Profile
Phase III trial of masitinib in paediatric patients with mastocytosis
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 17 Dec 2014
Price :
$35
*
At a glance
- Drugs Masitinib (Primary)
- Indications Mastocytosis
- Focus Registrational; Therapeutic Use
- Sponsors AB Science
- 17 Dec 2014 New trial record
- 10 Nov 2014 This trial is expected to be initiated in 2015, according to an AB Science media release.